Trial
NCT02794246
CART-19 Post-ASCT for Multiple Myeloma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Multiple Myeloma
Intervention
CART-19 cells
Why stopped
Study was terminated due to administrative reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-22